Trial Profile
Moxonidine in hypertensive patients with paroxysmal atrial fibrillation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Aug 2013
Price :
$35
*
At a glance
- Drugs Moxonidine (Primary)
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- 26 Aug 2013 New trial record
- 28 Feb 2013 Primary endpoint 'Paroxysmal-atrial-fibrillation' has been met.